|
Volumn 38, Issue 2, 2002, Pages 286-289
|
Synthesis of 1,3-bis[2-hydroxy-3-(3-methyl-5-oxo-2,5-dihydro-1-pyrazolyl)propyl)uracils
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
1,3 BIS(2 HYDROXY 3 CHLOROPROPYL) 6 METHYLURACIL;
1,3 BIS(2 HYDROXY 3 CHLOROPROPYL)URACIL;
1,3 BIS(3 HYDRAZINO 2 HYDROXYPROPYL) 6 METHYLURACIL;
1,3 BIS(3 HYDRAZINO 2 HYDROXYPROPYL)URACIL;
1,3 BIS[2 HYDROXY 3 (1 METHYL 2 ETHOXYCARBONYLETHYLIDENEHYDRAZINO)PROPYL] 6 METHYLURACIL;
1,3 BIS[2 HYDROXY 3 (1 METHYL 2 ETHOXYCARBONYLETHYLIDENEHYDRAZINO)PROPYL]URACIL;
1,3 BIS[2 HYDROXY 3 (3 METHYL 5 OXO 2,5 DIHYDRO 1 PYRAZOLYL)PROPYL] 6 METHYLURACIL;
1,3 BIS[2 HYDROXY 3 (3 METHYL 5 OXO 2,5 DIHYDRO 1 PYRAZOLYL)PROPYL]URACIL;
ACETOACETIC ACID DERIVATIVE;
ANTIINFLAMMATORY AGENT;
HYDRAZINE DERIVATIVE;
HYDRAZONE DERIVATIVE;
POTASSIUM CARBONATE;
PYRAZOLONE DERIVATIVE;
PYRIMIDINE DERIVATIVE;
UNCLASSIFIED DRUG;
URACIL DERIVATIVE;
ARTICLE;
CARBON NUCLEAR MAGNETIC RESONANCE;
DRUG SYNTHESIS;
PROTON NUCLEAR MAGNETIC RESONANCE;
QUANTUM YIELD;
REACTION ANALYSIS;
ROOM TEMPERATURE;
STRUCTURE ANALYSIS;
ULTRAVIOLET SPECTROSCOPY;
|
EID: 0036273925
PISSN: 10704280
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1015542422938 Document Type: Article |
Times cited : (2)
|
References (10)
|